CXCR2 and Patent ductus arteriosus: High level of CXCL5, a chemokine for the recruitment of neutrophils, as well as its receptor C-X-C chemokine receptor 2 (CXCR2), which is highly expressed on TANs, has been associated with poor outcome in PDA patients (68).